TARRA MANDEL: Open Payments
NPI 1770178097 · ALHAMBRA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 8 payments from 6 companies in 2025. Trend: 2023 $115 · 2024 $600 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Alkermes, Inc. | 3 | $48 |
| Neurocrine BioSciences, Inc. | 1 | $38 |
| Baxter Healthcare | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $16 |
Products named: COBENFY, ARISTADA, INGREZZA, FLOSEAL, UZEDY, VRAYLAR.
Industry payments across CA — which companies pay providers there.
